Slaughter and May have advised Alliance Pharmaceuticals Limited on the carve out and subsequent disposal of its pharmaceutical division

Slaughter and May have advised Alliance Pharmaceuticals Limited (“Alliance”) on the carve out and subsequent disposal of its pharmaceutical division to two unrelated UK pharmaceutical companies.

Alliance is a science-led consumer healthcare company focused on driving growth in high-potential, overlooked categories. Alliance’s scientifically designed products deliver effective results that empower consumers to restore their confidence. Headquartered in the UK, the Alliance employs around 290 people based in locations across Europe, North America, and the Asia Pacific region.